Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06335797 · ClinicalTrials.gov registry record · NA

Optimization of Postoperative Bowel Habits

A NA study of Constipation, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT06335797 is a NA study of Constipation that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 88 participants, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06335797, a NA study of Constipation, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

Project is a trial, in which women undergoing vaginal surgery for pelvic organ prolapse will be randomized 1:1 to a postoperative bowel regimen of either oral senna or rectal bisacodyl suppository.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Senna Tab
  • DIETARY_SUPPLEMENT Dulcolax Suppositories

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2024-10-16
Est. Completion 2027-05
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06335797

The ClinicalTrials.gov registry entry for NCT06335797 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (57% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Senna Tab is the first listed.

NCT06335797 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06335797 about?

NCT06335797 is a clinical study titled "Optimization of Postoperative Bowel Habits". Project is a trial, in which women undergoing vaginal surgery for pelvic organ prolapse will be randomized 1:1 to a postoperative bowel regimen of either oral senna or rectal bisacodyl suppository.

What is the current status of trial NCT06335797?

This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2024-10-16. Estimated completion is 2027-05.

What conditions does trial NCT06335797 study?

This clinical trial studies the following conditions: Constipation.

What interventions are being tested in trial NCT06335797?

The interventions under investigation include: Senna Tab (DIETARY_SUPPLEMENT), Dulcolax Suppositories (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06335797?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06335797 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.